Insider · CIK 0001834681
Ozan Pamir
Files at NAGE (ChromaDex Corp.). First filing Nov 25, 2024, latest Nov 17, 2025.
In brief
Ozan Pamir files SEC Form 4 as CFO at NAGE (ChromaDex Corp.). Since Nov 25, 2024, Ozan Pamir has reported 2 open-market buys worth $67k and 0 open-market sells worth $0, the latest filed on Nov 17, 2025.
A track record needs three past buys with six months of prices behind them; Ozan Pamir has 0, so none is measured yet.
The newest scored trade: bought $46k of NAGE on Nov 14, 2025, filed Nov 17, 2025, scored 46 (moderate). In the last 12 months: 1 buy worth $46k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NAGE: ChromaDex Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | NAGEbuy ChromaDex Corp. | $46k 6,685 shares | +230% | +31% from low-52% from high | |
| 30Weak | NAGEbuy ChromaDex Corp. | $21k 2,907 shares | - | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | NAGE ChromaDex Corp. | AGrant or award Common Stock | +4,255 | $2.71 | $12k | 11,627 | Jul 8, 2026 |
| Feb 19, 2026 | NAGE ChromaDex Corp. | AGrant or award Employee Stock Options (right to buy)derivative | +62,131 | $0.00 | $0 | 62,131 | Feb 24, 2026 |
| Nov 14, 2025 | NAGE ChromaDex Corp. | POpen-market purchase Common Stock | +4,465 | $6.81 | $30k | 7,372 | Nov 17, 2025 |
| Nov 14, 2025 | NAGE ChromaDex Corp. | POpen-market purchase Common Stockindirect: The reported securities are held by the reporting person's spouse. | +2,220 | $6.85 | $15k | 2,220 | Nov 17, 2025 |
| Feb 12, 2025 | NAGE ChromaDex Corp. | AGrant or award Employee Stock Options (right to buy)derivative | +17,230 | $0.00 | $0 | 17,230 | Feb 14, 2025 |
| Nov 22, 2024 | NAGE ChromaDex Corp. | POpen-market purchase Common Stock | +2,907 | $7.36 | $21k | 2,907 | Nov 25, 2024 |
| Oct 21, 2024 | NAGE ChromaDex Corp. | AGrant or award Employee Stock Options (right to buy)derivative | +146,544 | $0.00 | $0 | 146,544 | Oct 23, 2024 |
Questions about Ozan Pamir
Answered from the filings on this page, as of the latest one.
Is Ozan Pamir buying or selling?
In the last 12 months Ozan Pamir reported 1 open-market buy worth $46k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $46k of NAGE on Nov 14, 2025. Grants, option exercises and tax withholding are not counted.
How did Ozan Pamir's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ozan Pamir has 0.
Where does Ozan Pamir file Form 4?
Ozan Pamir has filed Form 4 at NAGE (ChromaDex Corp.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.